In 2018-2019 year in the Russian Arsenal of doctors there might be a cure for melanoma (skin cancer). Medicine - merit company BIOCAD, which for many years engaged in the development of anticancer drugs. By the end of 2014, the scientists plan to get effective molecule drug substances. The cost of development is more than 10 million rubles.
If all tests are successful, the drug gets into the clinic already in 2918-2019 year. First, it will get Russian patients with melanoma, then the tool will go in Latin America and Asia, where the company BIOCAD has subsidiaries. There is a possibility of access to the markets of Europe and USA.
The remedy for melanoma is a monoclonal antibody to the antigen PD-1. The drug stimulates the immune system, causing it to work to destroy cancer cells. While healthy cells remain intact. The plans for the development of such drugs for the treatment of kidney cancer and lung.